Amgen AMGN
CEO: Robert Bradway · Biotechnology · 27,000 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.5M | $5K | $20.5M | $5.5M | $3.5M | $98K | $31.2M |
| 2024 | $1.5M | — | $25.8M | $9.8M | $3.8M | $169K | $41.0M |
| 2023 | $1.4M | — | $22.7M | $3.9M | $6.9M | $117K | $35.3M |
| 2022 | $1.4M | — | $14.8M | $6.9M | $2.3M | $106K | $25.9M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Robert Bradway, CEO of Amgen (AMGN), earns $31.2M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Amgen has a Pay-for-Performance Score of B (70/100). The company's 3-year total shareholder return is +12.8%, and the say-on-pay shareholder vote passed with 85.7% approval.
The CEO-to-median-worker pay ratio at Amgen is 576:1. The median worker at Amgen earns $54K per year, while CEO Robert Bradway earns $31.2M in total compensation.
Amgen employs approximately 27,000 people. The company operates in the Biotechnology industry within the Healthcare sector, generating $28.2B in annual revenue.